Oral hyoscine butylbromide for irritable bowel syndrome?
نویسندگان
چکیده
منابع مشابه
Treatment of irritable bowel syndrome with lorazepam, hyoscine butylbromide, and ispaghula husk.
A double-blind controlled therapeutic trial of factorial design was used to study the therapeutic effects of lorazepam, hyoscine butylbromide, and ispaghula husk in 12 randomised blocks of eight patients with the irritable bowel syndrome (IBS). Each of the three agents caused a sustained symptomatic improvement in some of the patients, although only with ispaghula was the difference between the...
متن کاملDiets and Irritable Bowel Syndrome
Introduction: Irritable bowel syndrome (IBS) is the most common functional gastrointestinal disorder, which is characterized by the presence of abdominal pain or discomfort associated with altered bowel habits. This systematic review aimed to assess the nutritional factors (dietary patterns and food groups) associated with IBS. Methods: Articles were collected ...
متن کاملSOOTHING THE IRRITABLE BOWEL SYNDROME Soothing the Irritable Bowel Syndrome
of patient presentations at gastrointestinal clinics, and up to 50% or more of patients presenting with abdominal symptoms have no organic abnormality detected. The most common functional gastrointestinal conditions in Canada are irritable bowel syndrome (IBS), and functional dyspepsia or nonulcer dyspepsia (NUD). Other functional disorders may affect specific regions of the alimentary tract, s...
متن کاملRifaximin for Irritable Bowel Syndrome
The current treatments for irritable bowel syndrome (IBS) are suboptimal. The findings of previous studies of rifaximin treatment for IBS may have differed due to variations in study design. Our study aimed to determine the therapeutic and adverse effects of rifaximin treatment for IBS based on a meta-analysis of published randomized controlled trials (RCTs). We searched the MEDLINE, EMBASE, EB...
متن کاملAntidepressants for irritable bowel syndrome.
Systematic reports of antidepressant use in irritable bowel syndrome (IBS) first appeared in the medical literature three decades ago. Recent meta-analyses of the cumulative controlled experience confirm the efficacy of antidepressants in IBS and other functional gastrointestinal disorders: only 3–4 patients require treatment to demonstrate a benefit over placebo—numbers indicating a solid trea...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMJ
سال: 1979
ISSN: 0959-8138,1468-5833
DOI: 10.1136/bmj.1.6165.752-a